MMP9 and neoplasm: From our data, emodin modulated the TME in both tumor-bearing pancreas tissue (suppressing NF-κB and MMP-9) and metastasis-bearing hepatic tissue (increasing E-cadherin) in pancreas and splenic injection models, respectively [10,11].